Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of thiomersal-free FluLaval, thiomersal-containing FluLaval, and Fluarix influenza vaccines in adults and elderly subjects
2008-001445-26Phase 3Terminated
- Sponsor
- GSK
- Start
- Apr 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluzone Trivalent and Fluarix in influenza (3 arms), sponsored by GSK. Primary endpoint: Humoral immune response at 21 days. Started Apr 2008; status: terminated.
02
Drugs
Fluzone TrivalentFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-001445-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001445-26.